|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization of fixed assets | |||||
| Deferred income taxes | |||||
| Stock-based compensation | |||||
| Amortization of intangible assets | |||||
| Amortization of forgivable loans | |||||
| Decrease/(increase) in operating assets: | |||||
| Receivables from brokers, dealers and clearing organizations | |||||
| Net financial instruments and other inventory positions owned | |||||
| Investments | |||||
| Other assets | |||||
| Increase/(decrease) in operating liabilities: | |||||
| Payables to brokers, dealers and clearing organizations | |||||
| Accrued compensation | |||||
| Other liabilities and accrued expenses | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Business acquisitions, net of cash acquired | |||||
| Purchases of fixed assets, net | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Net change in short-term financing | |||||
| Repayment of long-term financing | |||||
| Payment of contingent consideration | |||||
| Payment of cash dividends | |||||
| Increase/(decrease) in noncontrolling interests | |||||
| Repurchase of common stock | |||||
| Proceeds from stock option exercises | |||||
| Net cash used in financing activities | |||||
| Currency adjustment: | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...